title: [Use of Bromocriptin tablets in physiologic and pathologic hyperprolactinemia].
abstract: The authors used Bromocriptine tablet, made by Chemical Works of Gedeon Richter Ltd. in 11 cases to alleriate a physiological milk secretion and in 15 cases as a treatment for extra-puerperal galactorrhea. Under treatment the serum prolactin level dropped exponentially while under Norcolut administration a linear regression was shown and the mammary activity abated after 14 days. The best method for treating the physiological hyperprolactinemia is to give the Bromocriptine before starting milk secretion. In cases of extra-puerperal galactorrhea. The patients become free from complaint after 8 weeks. In both cases the dose was 5-7.5 mg Bromocriptine. When galactorrhea and amenorrhoea occur together during the treatments second month menstruation begins and in two cases unwanted pregnancies happened. It has been found that the latent functional hyperprolactinemia can also be galactorrhea. The result were verified in ten cases by testing the metoclopramide-burden.
authors.affiliation: Markhot Ferenc Kórház Rendelöintézet, Szülészet-Nögyógyászati osztály és III, Eger.
authors.forename: M
authors.initials: M
authors.lastname: Farkas
authors.forename: C
authors.initials: C
authors.lastname: Tárczy
authors.forename: E
authors.initials: E
authors.lastname: Tasiné Tóth
authors.forename: J
authors.initials: J
authors.lastname: Bérczy
authors.forename: G
authors.initials: G
authors.lastname: Gyetvai
mesh_terms: D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy*; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D007247:Infertility, Female / Q000188:drug therapy; D007774:Lactation / Q000187:drug effects*; D009640:Norethindrone / Q000627:therapeutic use; D011247:Pregnancy; D013607:Tablets
chemical_list: D013607:Tablets; D001971:Bromocriptine; D009640:Norethindrone
vernacular_title: A Bromocriptin tabletta alkalmazása fiziológiás és pathológiás hiperprolaktinémiában.